0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genomics In Cancer Care Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: November 2022
|
Report Code: QYRE-Auto-2H6471
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Genomics In Cancer Care Market Insights Forecast to 2028
BUY CHAPTERS

Global Genomics In Cancer Care Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-2H6471
Report
November 2022
Pages:121
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Genomics In Cancer Care estimated at US$ 32040 million in the year 2022, is projected to reach a revised size of US$ 70990 million by 2028, growing at a CAGR of 14.2% during the forecast period 2022-2028.

The USA market for Genomics In Cancer Care is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Genomics In Cancer Care is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Genomics In Cancer Care is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Genomics In Cancer Care include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Genomics In Cancer Care companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Genomics In Cancer Care market. Further, it explains the major drivers and regional dynamics of the global Genomics In Cancer Care market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Pacific Biosciences
Quest Diagnostics
Luminex
Oxford Gene Technology
PerkinElmer
Qiagen
GE Healthcare
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Genomics In Cancer Care Segment by Type

Instruments
Consumables
Services

Genomics In Cancer Care Segment by Application

Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Genomics In Cancer Care market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Genomics In Cancer Care market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Genomics In Cancer Care, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genomics In Cancer Care, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genomics In Cancer Care revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Genomics In Cancer Care market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Genomics In Cancer Care revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Genomics In Cancer Care Market Size (2017-2028)
2.2 Genomics In Cancer Care Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Genomics In Cancer Care Market Size by Region (2017-2022)
2.4 Global Genomics In Cancer Care Market Size Forecast by Region (2023-2028)
2.5 Global Top Genomics In Cancer Care Countries Ranking by Market Size
3 Genomics In Cancer Care Competitive by Company
3.1 Global Genomics In Cancer Care Revenue by Players
3.1.1 Global Genomics In Cancer Care Revenue by Players (2017-2022)
3.1.2 Global Genomics In Cancer Care Market Share by Players (2017-2022)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2021
3.5 Global Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Revenue by Type (2017-2022)
4.2 Global Genomics In Cancer Care Forecasted Revenue by Type (2023-2028)
5 Global Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2017-2022)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomics In Cancer Care Revenue by Company (2020-2022)
6.2 North America Genomics In Cancer Care Revenue by Type (2017-2028)
6.3 North America Genomics In Cancer Care Revenue by Application (2017-2028)
6.4 North America Genomics In Cancer Care Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Revenue by Company (2020-2022)
7.2 Europe Genomics In Cancer Care Revenue by Type (2017-2028)
7.3 Europe Genomics In Cancer Care Revenue by Application (2017-2028)
7.4 Europe Genomics In Cancer Care Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Genomics In Cancer Care Revenue by Company (2020-2022)
8.2 Asia Pacific Genomics In Cancer Care Revenue by Type (2017-2028)
8.3 Asia Pacific Genomics In Cancer Care Revenue by Application (2017-2028)
8.4 Asia Pacific Genomics In Cancer Care Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Genomics In Cancer Care Revenue by Company (2020-2022)
9.2 Latin America Genomics In Cancer Care Revenue by Type (2017-2028)
9.3 Latin America Genomics In Cancer Care Revenue by Application (2017-2028)
9.4 Latin America Genomics In Cancer Care Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Genomics In Cancer Care Revenue by Company (2020-2022)
10.2 Middle East and Africa Genomics In Cancer Care Revenue by Type (2017-2028)
10.3 Middle East and Africa Genomics In Cancer Care Revenue by Application (2017-2028)
10.4 Middle East and Africa Genomics In Cancer Care Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Products and Services
11.1.4 Illumina Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.1.5 Illumina Genomics In Cancer Care SWOT Analysis
11.1.6 Illumina Recent Developments
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Details
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Products and Services
11.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.2.5 Thermo Fisher scientific Genomics In Cancer Care SWOT Analysis
11.2.6 Thermo Fisher scientific Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Products and Services
11.3.4 Agilent Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.3.5 Agilent Genomics In Cancer Care SWOT Analysis
11.3.6 Agilent Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Products and Services
11.4.4 Roche Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.4.5 Roche Genomics In Cancer Care SWOT Analysis
11.4.6 Roche Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Products and Services
11.5.4 Cancer Genetics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.5.5 Cancer Genetics Genomics In Cancer Care SWOT Analysis
11.5.6 Cancer Genetics Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Products and Services
11.6.4 Beckman Coulter Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.6.5 Beckman Coulter Genomics In Cancer Care SWOT Analysis
11.6.6 Beckman Coulter Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Products and Services
11.7.4 Bio-Rad Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.7.5 Bio-Rad Genomics In Cancer Care SWOT Analysis
11.7.6 Bio-Rad Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Products and Services
11.8.4 Danaher Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.8.5 Danaher Genomics In Cancer Care SWOT Analysis
11.8.6 Danaher Recent Developments
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Products and Services
11.9.4 Sigma Aldrich Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.9.5 Sigma Aldrich Genomics In Cancer Care SWOT Analysis
11.9.6 Sigma Aldrich Recent Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Details
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Products and Services
11.10.4 Pacific Biosciences Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.10.5 Pacific Biosciences Genomics In Cancer Care SWOT Analysis
11.10.6 Pacific Biosciences Recent Developments
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Details
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Products and Services
11.11.4 Quest Diagnostics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.11.5 Quest Diagnostics Recent Developments
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Products and Services
11.12.4 Luminex Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.12.5 Luminex Recent Developments
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Details
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Products and Services
11.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.13.5 Oxford Gene Technology Recent Developments
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Products and Services
11.14.4 PerkinElmer Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.14.5 PerkinElmer Recent Developments
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Products and Services
11.15.4 Qiagen Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.15.5 Qiagen Recent Developments
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Products and Services
11.16.4 GE Healthcare Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022)
11.16.5 GE Healthcare Recent Developments
12 Genomics In Cancer Care Market Dynamics
12.1 Genomics In Cancer Care Market Trends
12.2 Genomics In Cancer Care Market Drivers
12.3 Genomics In Cancer Care Market Challenges
12.4 Genomics In Cancer Care Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
    Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Instruments
    Table 3. Key Players of Consumables
    Table 4. Key Players of Services
    Table 5. Global Genomics In Cancer Care Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Genomics In Cancer Care Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 7. Global Genomics In Cancer Care Revenue by Region (2017-2022) & (US$ Million)
    Table 8. Global Genomics In Cancer Care Revenue Market Share by Region (2017-2022)
    Table 9. Global Genomics In Cancer Care Revenue by Players (2017-2022) & (US$ Million)
    Table 10. Global Genomics In Cancer Care Market Share by Players (2017-2022)
    Table 11. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
    Table 12. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2021
    Table 13. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2017-2022)
    Table 14. Key Players Headquarters and Area Served
    Table 15. Key Players Genomics In Cancer Care Product Solution and Service
    Table 16. Date of Key Manufacturers Enter into Genomics In Cancer Care Market
    Table 17. Mergers & Acquisitions, Expansion Plans
    Table 18. Global Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
    Table 19. Global Genomics In Cancer Care Revenue Market Share by Type (2017-2022)
    Table 20. Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 21. Global Genomics In Cancer Care Revenue Market Share by Type (2023-2028)
    Table 22. Global Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
    Table 23. Global Genomics In Cancer Care Revenue Market Share by Application (2017-2022)
    Table 24. Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 25. Global Genomics In Cancer Care Revenue Market Share by Application (2023-2028)
    Table 26. North America Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
    Table 27. North America Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
    Table 28. North America Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
    Table 29. North America Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
    Table 30. North America Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
    Table 31. North America Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
    Table 32. North America Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
    Table 33. Europe Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
    Table 34. Europe Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Europe Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Europe Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
    Table 37. Europe Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
    Table 38. Europe Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
    Table 39. Europe Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
    Table 40. Asia Pacific Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
    Table 41. Asia Pacific Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Asia Pacific Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Genomics In Cancer Care Revenue by Region (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Genomics In Cancer Care Revenue by Region (2023-2028) & (US$ Million)
    Table 47. Latin America Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
    Table 48. Latin America Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
    Table 49. Latin America Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
    Table 50. Latin America Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
    Table 51. Latin America Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
    Table 52. Latin America Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
    Table 53. Latin America Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
    Table 54. Middle East and Africa Genomics In Cancer Care Revenue by Company (2020-2022) & (US$ Million)
    Table 55. Middle East and Africa Genomics In Cancer Care Revenue by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Genomics In Cancer Care Revenue by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Genomics In Cancer Care Revenue by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Genomics In Cancer Care Revenue by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Genomics In Cancer Care Revenue by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Genomics In Cancer Care Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Illumina Company Details
    Table 62. Illumina Business Overview
    Table 63. Illumina Genomics In Cancer Care Product and Services
    Table 64. Illumina Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 65. Illumina Genomics In Cancer Care SWOT Analysis
    Table 66. Illumina Recent Developments
    Table 67. Thermo Fisher scientific Company Details
    Table 68. Thermo Fisher scientific Business Overview
    Table 69. Thermo Fisher scientific Genomics In Cancer Care Product and Services
    Table 70. Thermo Fisher scientific Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 71. Thermo Fisher scientific Genomics In Cancer Care SWOT Analysis
    Table 72. Thermo Fisher scientific Recent Developments
    Table 73. Agilent Company Details
    Table 74. Agilent Business Overview
    Table 75. Agilent Genomics In Cancer Care Product and Services
    Table 76. Agilent Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 77. Agilent Genomics In Cancer Care SWOT Analysis
    Table 78. Agilent Recent Developments
    Table 79. Roche Company Details
    Table 80. Roche Business Overview
    Table 81. Roche Genomics In Cancer Care Product and Services
    Table 82. Roche Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 83. Roche Genomics In Cancer Care SWOT Analysis
    Table 84. Roche Recent Developments
    Table 85. Cancer Genetics Company Details
    Table 86. Cancer Genetics Business Overview
    Table 87. Cancer Genetics Genomics In Cancer Care Product and Services
    Table 88. Cancer Genetics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 89. Cancer Genetics Genomics In Cancer Care SWOT Analysis
    Table 90. Cancer Genetics Recent Developments
    Table 91. Beckman Coulter Company Details
    Table 92. Beckman Coulter Business Overview
    Table 93. Beckman Coulter Genomics In Cancer Care Product and Services
    Table 94. Beckman Coulter Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 95. Beckman Coulter Genomics In Cancer Care SWOT Analysis
    Table 96. Beckman Coulter Recent Developments
    Table 97. Bio-Rad Company Details
    Table 98. Bio-Rad Business Overview
    Table 99. Bio-Rad Genomics In Cancer Care Product and Services
    Table 100. Bio-Rad Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 101. Bio-Rad Genomics In Cancer Care SWOT Analysis
    Table 102. Bio-Rad Recent Developments
    Table 103. Danaher Company Details
    Table 104. Danaher Business Overview
    Table 105. Danaher Genomics In Cancer Care Product and Services
    Table 106. Danaher Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 107. Danaher Genomics In Cancer Care SWOT Analysis
    Table 108. Danaher Recent Developments
    Table 109. Sigma Aldrich Company Details
    Table 110. Sigma Aldrich Business Overview
    Table 111. Sigma Aldrich Genomics In Cancer Care Product and Services
    Table 112. Sigma Aldrich Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 113. Sigma Aldrich Genomics In Cancer Care SWOT Analysis
    Table 114. Sigma Aldrich Recent Developments
    Table 115. Pacific Biosciences Company Details
    Table 116. Pacific Biosciences Business Overview
    Table 117. Pacific Biosciences Genomics In Cancer Care Product and Services
    Table 118. Pacific Biosciences Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 119. Pacific Biosciences Genomics In Cancer Care SWOT Analysis
    Table 120. Pacific Biosciences Recent Developments
    Table 121. Quest Diagnostics Company Details
    Table 122. Quest Diagnostics Business Overview
    Table 123. Quest Diagnostics Genomics In Cancer Care Product and Services
    Table 124. Quest Diagnostics Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 125. Quest Diagnostics Recent Developments
    Table 126. Luminex Company Details
    Table 127. Luminex Business Overview
    Table 128. Luminex Genomics In Cancer Care Product and Services
    Table 129. Luminex Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 130. Luminex Recent Developments
    Table 131. Oxford Gene Technology Company Details
    Table 132. Oxford Gene Technology Business Overview
    Table 133. Oxford Gene Technology Genomics In Cancer Care Product and Services
    Table 134. Oxford Gene Technology Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 135. Oxford Gene Technology Recent Developments
    Table 136. PerkinElmer Company Details
    Table 137. PerkinElmer Business Overview
    Table 138. PerkinElmer Genomics In Cancer Care Product and Services
    Table 139. PerkinElmer Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 140. PerkinElmer Recent Developments
    Table 141. Qiagen Company Details
    Table 142. Qiagen Business Overview
    Table 143. Qiagen Genomics In Cancer Care Product and Services
    Table 144. Qiagen Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 145. Qiagen Recent Developments
    Table 146. GE Healthcare Company Details
    Table 147. GE Healthcare Business Overview
    Table 148. GE Healthcare Genomics In Cancer Care Product and Services
    Table 149. GE Healthcare Genomics In Cancer Care Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
    Table 150. GE Healthcare Recent Developments
    Table 151. Genomics In Cancer Care Market Trends
    Table 152. Genomics In Cancer Care Market Drivers
    Table 153. Genomics In Cancer Care Market Challenges
    Table 154. Genomics In Cancer Care Market Restraints
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomics In Cancer Care Sales Market Share by Type: 2021 VS 2028
    Figure 2. Instruments Features
    Figure 3. Consumables Features
    Figure 4. Services Features
    Figure 5. Global Genomics In Cancer Care Sales Market Share by Application: 2021 VS 2028
    Figure 6. Diagnostics Case Studies
    Figure 7. Personalized Medicine Case Studies
    Figure 8. Drug Discovery Case Studies
    Figure 9. Development Case Studies
    Figure 10. Research Case Studies
    Figure 11. Genomics In Cancer Care Report Years Considered
    Figure 12. Global Genomics In Cancer Care Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Genomics In Cancer Care Market Size 2017-2028 (US$ Million)
    Figure 14. Global Genomics In Cancer Care Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global Genomics In Cancer Care Revenue Market Share by Region in 2017 VS 2022
    Figure 16. Global Top 10 Genomics In Cancer Care Countries Ranking by Market Size (US$ Million) in 2021
    Figure 17. Global Genomics In Cancer Care Market Share by Players in 2021
    Figure 18. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2021
    Figure 20. North America Genomics In Cancer Care Revenue Market Share by Company in 2021
    Figure 21. North America Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
    Figure 22. North America Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
    Figure 23. North America Genomics In Cancer Care Revenue Share by Country (2017-2028)
    Figure 24. U.S. Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 25. Canada Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 26. Europe Genomics In Cancer Care Revenue Market Share by Company in 2021
    Figure 27. Europe Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
    Figure 28. Europe Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
    Figure 29. Europe Genomics In Cancer Care Revenue Share by Country (2017-2028)
    Figure 30. Germany Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 31. France Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 32. U.K. Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 33. Italy Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 34. Russia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Genomics In Cancer Care Revenue Market Share by Company in 2021
    Figure 36. Asia Pacific Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Genomics In Cancer Care Revenue Share by Region (2017-2028)
    Figure 39. China Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 40. Japan Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 41. South Korea Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 42. India Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 43. Australia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 44. Taiwan Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 45. Indonesia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 46. Thailand Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 47. Malaysia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 48. Philippines Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 49. Vietnam Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 50. Latin America Genomics In Cancer Care Revenue Market Share by Company in 2021
    Figure 51. Latin America Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
    Figure 52. Latin America Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
    Figure 53. Latin America Genomics In Cancer Care Revenue Share by Country (2017-2028)
    Figure 54. Mexico Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 55. Brazil Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 56. Argentina Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Company in 2021
    Figure 58. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Genomics In Cancer Care Revenue Share by Country (2017-2028)
    Figure 61. Turkey Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 63. UAE Genomics In Cancer Care Revenue (2017-2028) & (US$ Million)
    Figure 64. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 65. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 66. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 67. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 68. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 69. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 70. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 71. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 72. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 73. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 74. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 75. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 76. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 77. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 78. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 79. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS